Preferred Label : Leukodystrophy, demyelinating, adult-onset, autosomal dominant;
Symbol : ADLD;
CISMeF acronym : ADLD;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Pelizaeus-merzbacher disease, autosomal dominant or late-onset type;
Description : Autosomal dominant adult-onset demyelinating leukodystrophy is a slowly progressive
and fatal disorder that presents in the fourth or fifth decade of life and is characterized
clinically by early autonomic abnormalities, pyramidal and cerebellar dysfunction,
and symmetric demyelination of the CNS. ADLD differs from multiple sclerosis and other
demyelinating disorders in that neuropathology shows preservation of oligodendroglia
in the presence of subtotal demyelination and lack of astrogliosis (summary by Padiath
et al., 2006). Characteristic MRI findings include T2-weighted hyperintense changes
in the upper corticospinal tract and cerebellar peduncles, with later development
of confluent white matter changes in the frontoparietal area with relative sparing
of the periventricular white matter (summary by Schuster et al., 2011).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by duplication of 72 kb of 5q23.2 including at a minimum the lamin B1 gene
(LMNB1, 150340.0001);
Laboratory abnormalities : Patient cells have increased levels of LMNB1 mRNA and protein;
Prefixed ID : #169500;
Origin ID : 169500;
UMLS CUI : C1868512;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)